These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33043078)

  • 1. Association Between Olfactory Impairment and Disease Severity and Duration in Parkinson's Disease.
    Sasaki S; Horie Y
    Mov Disord Clin Pract; 2020 Oct; 7(7):820-826. PubMed ID: 33043078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Early Parkinson's Disease in Patients With Subtle Parkinsonian Signs.
    Sasaki S
    Front Neurol; 2021; 12():656679. PubMed ID: 34305780
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.
    Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A
    J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.
    Hattori T; Orimo S; Hallett M; Wu T; Inaba A; Azuma R; Mizusawa H
    Acta Neurol Scand; 2014 Dec; 130(6):347-53. PubMed ID: 25209841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Olfactory Deficit and Motor and Cognitive Function in Parkinson's Disease.
    Yoo HS; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee PH
    J Mov Disord; 2020 May; 13(2):133-141. PubMed ID: 32241078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson's disease: A multicenter cross-sectional study.
    Iijima M; Okuma Y; Suzuki K; Yoshii F; Nogawa S; Osada T; Hirata K; Kitagawa K; Hattori N
    PLoS One; 2021; 16(2):e0247443. PubMed ID: 33606814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olfactory function combined with morphology distinguishes Parkinson's disease.
    Sengoku R; Matsushima S; Bono K; Sakuta K; Yamazaki M; Miyagawa S; Komatsu T; Mitsumura H; Kono Y; Kamiyama T; Ito K; Mochio S; Iguchi Y
    Parkinsonism Relat Disord; 2015 Jul; 21(7):771-7. PubMed ID: 25986741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease.
    Fang TC; Chang MH; Yang CP; Chen YH; Lin CH
    Front Neurol; 2021; 12():779712. PubMed ID: 34880827
    [No Abstract]   [Full Text] [Related]  

  • 9. Olfactory Dysfunction Predicts Disease Progression in Parkinson's Disease: A Longitudinal Study.
    He R; Zhao Y; He Y; Zhou Y; Yang J; Zhou X; Zhu L; Zhou X; Liu Z; Xu Q; Sun Q; Tan J; Yan X; Tang B; Guo J
    Front Neurosci; 2020; 14():569777. PubMed ID: 33381006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual idiopathic normal pressure hydrocephalus patient with marked asymmetric and upper body parkinsonism.
    Kang K; Choi D; Lee HW
    Ann Indian Acad Neurol; 2016; 19(2):245-8. PubMed ID: 27293338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Among Early Appearing Non-Motor Signs of Parkinson's Disease, Alteration of Olfaction but Not Electroencephalographic Spectrum Correlates with Motor Function.
    Cozac VV; Auschra B; Chaturvedi M; Gschwandtner U; Hatz F; Meyer A; Welge-Lüssen A; Fuhr P
    Front Neurol; 2017; 8():545. PubMed ID: 29104561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
    Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
    JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal Dopamine Deficit and Motor Impairment in Idiopathic Normal Pressure Hydrocephalus.
    Pozzi NG; Brumberg J; Todisco M; Minafra B; Zangaglia R; Bossert I; Trifirò G; Ceravolo R; Vitali P; Isaias IU; Fasano A; Pacchetti C
    Mov Disord; 2021 Jan; 36(1):124-132. PubMed ID: 33151012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlating Parkinson's disease motor symptoms with three-dimensional [(18)F]FP-CIT PET.
    Chung M; Park YS; Kim JS; Kim YJ; Ma HI; Jang SJ; Huh R; Kim HS; Kim WC
    Jpn J Radiol; 2015 Oct; 33(10):609-18. PubMed ID: 25952404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?
    Sheng MZ; Fang TC; Chen YH; Chang MH; Yang CP; Lin CH
    PLoS One; 2021; 16(6):e0252451. PubMed ID: 34086764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and
    Kuya K; Ogawa T; Shinohara Y; Ishibashi M; Fujii S; Mukuda N; Tanabe Y
    Acta Radiol; 2018 May; 59(5):593-598. PubMed ID: 28743197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS).
    Monastero R; Cicero CE; Baschi R; Davì M; Luca A; Restivo V; Zangara C; Fierro B; Zappia M; Nicoletti A
    J Neurol; 2018 May; 265(5):1050-1058. PubMed ID: 29478221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.